Shares of hVIVO plc (LON:HVO – Get Free Report) were down 6.8% during mid-day trading on Friday . The stock traded as low as GBX 19 ($0.24) and last traded at GBX 19.10 ($0.24). Approximately 2,518,262 shares changed hands during mid-day trading, a decline of 26% from the average daily volume of 3,389,765 shares. The stock had previously closed at GBX 20.50 ($0.25).
hVIVO Stock Performance
The company has a debt-to-equity ratio of 33.86, a quick ratio of 1.16 and a current ratio of 1.61. The firm has a market cap of £129.95 million, a P/E ratio of 636.67 and a beta of 0.97. The business’s 50-day simple moving average is GBX 23.20 and its 200 day simple moving average is GBX 26.66.
About hVIVO
hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model.
Read More
- Five stocks we like better than hVIVO
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Quantum Opportunity: Skywater Technology’s Long-Term Potential
- Conference Calls and Individual Investors
- Nebius Group: The Rising Star in AI Infrastructure
- How to Plot Fibonacci Price Inflection Levels
- MarketBeat Week in Review – 12/30 – 1/03
Receive News & Ratings for hVIVO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for hVIVO and related companies with MarketBeat.com's FREE daily email newsletter.
